- state & global data
- view as grid
- view as list
As the country gears up for implementation of the major provisions of the Affordable Care Act (ACA), June’s Kaiser Health Tracking Poll takes a step back and examines views on health insurance more broadly among some key subgroups, including young adults, the uninsured, and those with pre-existing conditions. The poll finds that the large majority of Americans want and value health insurance.
Amid increasing state and national interest in using managed care delivery models for Medicaid beneficiaries, the Kaiser Family Foundation’s Commission on Medicaid and the Uninsured will host a public briefing from 12:00 Noon to 1:30 p.m. ET on Tuesday, June 25 to provide information on recent transitions from fee-for-service to managed care,…
An Analysis of the Share of Medicare Beneficiaries Who Would Benefit from an Annual Out-of-Pocket Maximum under Traditional Medicare Over Multiple Years
This analysis examines the share of Medicare beneficiaries who would be helped over time if the program were to add a limit on out-of-pocket spending to traditional Medicare. This analysis was conducted jointly with the Medicare Payment Advisory Commission (MedPAC) in response to a request made during a Feb. 26, 2013 hearing of the House Ways and Means’ Subcommittee on Health.
As one of the cornerstones of global health, widespread immunization through vaccines is critical to reducing child mortality and eradicating polio, two goals endorsed by the international community and particularly emphasized by the U.S. government. This live, interactive webcast explores the importance of vaccines in global child survival efforts, including the role of the U.S. government, the GAVI Alliance, and NGOs. Panelists discuss the current state of childhood immunization, global investments in vaccines, and the opportunities and challenges faced by key stakeholders. This webcast is part of “U.S. Global Health Policy: In Focus”, a Kaiser Family Foundation studio webcast series devoted to discussing current and critical issues facing the U.S.
The Food and Drug Administration has approved two vaccines against infection by certain strains of human papillomavirus (HPV), the most common sexually transmitted infection in the United States. Initially, the vaccines were recommended only for girls and young women, but in 2011 the Centers for Disease Control and Prevention broadened them to include boys and young men. This fact sheet discusses HPV and cancers related to the virus, use of the HPV vaccines for both females and males, and insurance coverage and access to the vaccines.
This brief finds that people of color will be disproportionately impacted by state decisions to expand Medicaid and that the impact of current state Medicaid expansion decisions varies widely by race and ethnicity, with Blacks at the highest risk of continuing to face coverage gaps and remaining uninsured due to state decisions not to expand at this time. As such, state Medicaid expansion decisions have important implications for efforts to reduce disparities and promote greater equity in health coverage and care.
Walgreens and Greater Than AIDS Team With Health Departments and Local AIDS Service Organizations to Provide Free HIV Testing in Support of National HIV Testing Day
HIV Testing Events Being Held at 175 Walgreens Locations in 54 Cities June 27-29 Thursday, June 13, 2013 – Walgreens, the nation’s largest drugstore chain (NYSE: WAG) (Nasdaq: WAG), and Greater Than AIDS, a coalition of public and private sector partners united in response to the domestic AIDS epidemic, are…
This Policy Insight explores possible explanations for the continued rise in Medicare Advantage enrollment between 2010 and 2013 in spite of a projected decrease following payment changes in the Affordable Care Act (ACA).
This June 10 briefing looked at Medicare Advantage and changes affecting it, including revised calculations of payments from CMS, and the Affordable Care Act’s reduced payments to Medicare Advantage plans. Speakers discussed how Medicare Advantage plans are expected to respond to payment changes; if quality bonus payments created significant changes in patient care or plan choices; and what implications could these decisions have on beneficiaries with regard to premiums, benefits and more.